Projects per year
Personal profile
Biography
Position
Professor of Pharmacy Practice
Centre for Medicine Use and Safety
Faculty of Pharmacy and Pharmaceutical Sciences
Research interests
- Population pharmacokinetic and pharmacodynamic modelling
- Monitoring and Bayesian optimisation of dosing of antibacterial agents (especially aminoglycosides)
- Optimisation of dosing in renal dysfunction
- Pharmacokinetics and dosing in obesity
- Drugs in breast milk
- Quality use of medicines
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Aminoglycosides
- Dosing of Antibacterial Agents
- Drugs in Breast Milk
- Medicine Use and Safety
- Obesity
- Optimisation of Dosing
- Pharmacodynamics
- Pharmacokinetics
- Quality Use of Medicines
- Renal Dysfunction
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MMQPA: Monash-Moderna Quantitative Pharmacology Accelerator
Kirkpatrick, C. (Primary Chief Investigator (PCI)), Landersdorfer, C. (Chief Investigator (CI)) & Porter, C. (Chief Investigator (CI))
Monash University – Internal University Contribution
15/08/23 → 14/08/28
Project: Research
-
Advancing Preclinical Development of Novel GPCR-targeted Therapeutics for Heart Failure
Ritchie, R. (Primary Chief Investigator (PCI)), Figtree, G. A. (Chief Investigator (CI)), Qin, C. H. (Chief Investigator (CI)), May, L. (Chief Investigator (CI)), Nicholls, S. (Chief Investigator (CI)), Taylor, A. (Chief Investigator (CI)), Yang, J. Y. H. (Chief Investigator (CI)), Shackleford, D. (Chief Investigator (CI)), Schiattarella, G. (Chief Investigator (CI)), Pinto, A. (Chief Investigator (CI)), Drummond, G. (Chief Investigator (CI)), Horowitz, J. D. (Chief Investigator (CI)), Bubb, K. (Chief Investigator (CI)), Ng, H. H. (Chief Investigator (CI)), Vecchio, L. (Associate Investigator (AI)), Nelson, A. (Associate Investigator (AI)), Kirkpatrick, C. (Associate Investigator (AI)), McDonald, C. (Associate Investigator (AI)), Febbraio, M. (Associate Investigator (AI)), Vinh, A. (Associate Investigator (AI)), Odiba, J. (Associate Investigator (AI)), Brown, H. (Associate Investigator (AI)) & Stupple, P. (Chief Investigator (CI))
1/02/23 → 31/01/26
Project: Research
-
Advanced development of therapeutics against bacterial pathogens of biowarfare concern
Kirkpatrick, C. & Sarkar-Tyson, M.
Project: Research
-
Advanced optimisation and screening of antivirulence compounds against biological warfare pathogens
Sarkar-Tyson, M. (Primary Chief Investigator (PCI)), Stubbs, K. (Chief Investigator (CI)), Debowski, A. (Chief Investigator (CI)), Bzdyl, N. (Chief Investigator (CI)), Kirkpatrick, C. (Chief Investigator (CI)) & Baell, J. (Chief Investigator (CI))
Defence Materials Technology Centre (DMTC)
14/02/22 → 14/08/23
Project: Research
-
Inhaled Oxytocin for Improved Maternal Health in Australia & Globally
McIntosh, M. (Primary Chief Investigator (PCI)), Lambert, P. (Chief Investigator (CI)) & Kirkpatrick, C. (Chief Investigator (CI))
1/01/22 → 31/12/23
Project: Research
-
A physiological approach to renal clearance: From premature neonates to adults
Holford, N., O'Hanlon, C. J., Allegaert, K., Anderson, B., Falcão, A., Simon, N., Lo, Y. L., Thomson, A. H., Sherwin, C. M., Jacqz-Aigrain, E., Llanos-Paez, C., Hennig, S., Mockus, L. & Kirkpatrick, C., Apr 2024, In: British Journal of Clinical Pharmacology. 90, 4, p. 1066-1080 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Citations (Scopus) -
Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour
Bijttebier, S., Nguyen, T. H., McIntosh, M. P., Kirkpatrick, C., Remmerie, B., Dillen, L. & Lambert, P., Oct 2024, In: British Journal of Clinical Pharmacology. 90, 10, p. 2562-2570 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
Lingaratnam, S., Shah, M., Nicolazzo, J., Michael, M., Seymour, J. F., James, P., Lazarakis, S., Loi, S. & Kirkpatrick, C. M. J., May 2024, In: Clinical and Translational Science. 17, 5, 23 p., e13781.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access2 Citations (Scopus) -
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia
Mostafa, S., Rafizadeh, R., Polasek, T. M., Bousman, C. A., Rostami-Hodjegan, A., Stowe, R., Carrion, P., Sheffield, L. J. & Kirkpatrick, C. M. J., Mar 2024, In: CPT: Pharmacometrics & Systems Pharmacology. 13, 3, p. 424-436 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
An evaluation of the Australian Community Pharmacy Agreement from a public policy perspective: industry policy cloaked as health policy?
Jackson, J. K., Scahill, S. L., Mintrom, M. & Kirkpatrick, C. M., Jun 2023, In: Journal of Pharmaceutical Policy and Practice. 16, 1, 13 p., 71.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)
Activities
-
Chairperson
Carl Kirkpatrick (Member)
21 Sept 2011Activity: External Academic Engagement › Submissions to industry or govt committees, commissions and inquiries
-
Co-director
Carl Kirkpatrick (Member)
1 Jan 2011Activity: External Academic Engagement › Grant review responsibilities
-
Member of Organising Committee
Carl Kirkpatrick (Member)
21 Sept 2011Activity: External Academic Engagement › Submissions to industry or govt committees, commissions and inquiries
-
ACPM Pharmaceutical subcommittee (PSC)
Kirkpatrick, C. (Member)
21 Sept 2011Activity: External Academic Engagement › Submissions to industry or govt committees, commissions and inquiries